Brian Rowe
Corporate Officer/Principal bij ATEA PHARMACEUTICALS, INC.
Profiel
Brian Rowe is currently the Vice President of Business Development at Atea Pharmaceuticals, Inc. He previously worked as the Senior Director of Business Development at Radius Health, Inc. and as the Senior Director of Marketing Operations at Tesaro, Inc. Mr. Rowe completed his undergraduate degree at Bowdoin College and holds an MBA from The Wharton School of the University of Pennsylvania.
Actieve functies van Brian Rowe
| Bedrijven | Functie | Begin |
|---|---|---|
| ATEA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Eerdere bekende functies van Brian Rowe
| Bedrijven | Functie | Einde |
|---|---|---|
| TESARO INC | Verkoop & Marketing | - |
| RADIUS HEALTH, INC. | Corporate Officer/Principal | - |
Opleiding van Brian Rowe
| Bowdoin College | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ATEA PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
